xml: <clinical_study>
    <!-- This xml conforms to an XML Schema at:
      https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
    <required_header>
      <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
      <link_text>Link to the current ClinicalTrials.gov record.</link_text>
      <url>https://clinicaltrials.gov/ct2/show/NCT06038851</url>
    </required_header>
    <id_info>
      <org_study_id>23.116</org_study_id>
      <nct_id>NCT06038851</nct_id>
    </id_info>
    <brief_title>Evaluation of the Analgesic Benefit of Adding the Blocks of the Intermediate and Medial Femoral Cutaneous Nerves in Addition to the Femoral Triangle Block for Postoperative Analgesia After a Knee Replacement Surgery</brief_title>
    <official_title>Evaluation of the Analgesic Benefit of Adding the Blocks of the Intermediate and Medial Femoral Cutaneous Nerves in Addition to the Femoral Triangle Block for Postoperative Analgesia After a Knee Replacement Surgery: A Randomized Controlled Clinical Trial</official_title>
    <sponsors>
      <lead_sponsor>
        <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
        <agency_class>Other</agency_class>
      </lead_sponsor>
    </sponsors>
    <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
    <oversight_info>
      <has_dmc>No</has_dmc>
      <is_fda_regulated_drug>No</is_fda_regulated_drug>
      <is_fda_regulated_device>No</is_fda_regulated_device>
    </oversight_info>
    <brief_summary>
      <textblock>
        Total knee replacement surgery can be associated with a significant postoperative pain burden&#xD;
        and an inability to mobilize adequately, which can lead to the failure of the ambulatory&#xD;
        course.&#xD;
  &#xD;
        Indeed, early mobilization is beneficial in this context in order to prevent complications&#xD;
        related to immobility.&#xD;
  &#xD;
        The optimization of postoperative analgesia is therefore a key issue for the success of this&#xD;
        intervention in an outpatient setting or during a short-term hospitalization since an&#xD;
        adequate pain relief facilitate the earlier mobilization of the operated joint. Modern&#xD;
        postoperative analgesia protocols recommend a multimodal approach, including the use of&#xD;
        acetaminophen, anti-inflammatories, opioids and others as well as the use of nerve blocks.&#xD;
  &#xD;
        Some nerve blocks used for total knee replacement surgery, such as the femoral nerve block,&#xD;
        do not preserve the motor skills of the operated limb, which may alter the clinical&#xD;
        trajectory due to delayed mobilization due to weakening of the quadriceps, one of the&#xD;
        extensor muscles of the knee. Currently, one of the blocks used to spare the motor functions&#xD;
        is the block of the femoral triangle.&#xD;
  &#xD;
        Unfortunately, this block of the femoral triangle does not fully cover the skin component of&#xD;
        the surgical incision used for a total knee arthroplasty. A solution to obtain a better&#xD;
        quality of pain relief at the level of the cutaneous incision would be to add a block of the&#xD;
        para-sartorial compartment, which makes it possible to cover the nerve territories not&#xD;
        covered by the femoral triangle block.&#xD;
  &#xD;
        The hypothesis of this study is that the addition of the para-sartorial compartments (PACS)&#xD;
        block, which aims to block the intermediate cutaneous femoral nerve, will improve the&#xD;
        postoperative analgesia after total knee replacement surgery, compared to the classical&#xD;
        isolated approach of the femoral triangle block (FTB).&#xD;
      </textblock>
    </brief_summary>
    <detailed_description>
      <textblock>
        Despite many advances, the postoperative analgesia offered by the present techniques remains&#xD;
        imperfect, the femoral triangle block does not make it possible to completely cover the&#xD;
        cutaneous component of the classic midline incision used for a total knee arthroplasty. This&#xD;
        incision would fall more under the anterior cutaneous femoral nerves, more specifically the&#xD;
        intermediate and medial cutaneous femoral nerves. A recently described approach offers the&#xD;
        prospect of better covering this skin incision, by specifically blocking these nerves using&#xD;
        the same needle path as for the femoral triangle block. Although the feasibility of this&#xD;
        approach has been studied in healthy volunteers and in a few clinical cases, no randomized&#xD;
        controlled study has been conducted to determine whether the addition of cutaneous femoral&#xD;
        nerve blocks offers an analgesic benefit in the population undergoing total knee replacement&#xD;
        surgery. This is therefore necessary in order to assess whether this approach improves the&#xD;
        clinical trajectory of patients receiving a total knee arthroplasty.&#xD;
      </textblock>
    </detailed_description>
    <overall_status>Not yet recruiting</overall_status>
    <start_date type="Anticipated">October 2023</start_date>
    <completion_date type="Anticipated">December 2024</completion_date>
    <primary_completion_date type="Anticipated">October 2024</primary_completion_date>
    <phase>N/A</phase>
    <study_type>Interventional</study_type>
    <has_expanded_access>No</has_expanded_access>
    <study_design_info>
      <allocation>Randomized</allocation>
      <intervention_model>Parallel Assignment</intervention_model>
      <intervention_model_description>Single-center, prospective superiority study, randomized controlled, triple blind</intervention_model_description>
      <primary_purpose>Prevention</primary_purpose>
      <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    </study_design_info>
    <primary_outcome>
      <measure>Total morphine consumption</measure>
      <time_frame>24 hours after the surgery</time_frame>
    </primary_outcome>
    <secondary_outcome>
      <measure>Time between the end of surgery and the first opioid dose</measure>
      <time_frame>24 hours after the surgery</time_frame>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Intensity of the postoperative pain</measure>
      <time_frame>24 hours, 72 hours and 7 days after the surgery</time_frame>
      <description>The Pain Intensity short form is universal rather than disease-specific. The first two items in the Pain Intensity item bank assess pain intensity utilizing a 7-day recall period (items include the phrase &quot;the past 7 days&quot;) while the last item asks patient to rate their pain intensity &quot;right now.&quot;</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Percentage of time spent with moderate to severe pain</measure>
      <time_frame>6 hours, 12 hours, 18 hours and 24 hours after the surgery</time_frame>
      <description>Percentage of time spent with moderate to severe pain (&gt; 4/10) using a numerical scale where 0 = no pain and 10 = worst pain imaginable</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Minimum pain after the surgery</measure>
      <time_frame>24 hours after the surgery</time_frame>
      <description>Minimum pain reported by the patient, rated on a numerical scale where 0 = no pain and 10 = worst pain imaginable.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Maximum pain after the surgery</measure>
      <time_frame>24 hours after the surgery</time_frame>
      <description>Maximum pain reported by the patient, rated on a numerical scale where 0 = no pain and 10 = worst pain imaginable.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Pain levels</measure>
      <time_frame>6 hours, 12 hours, 18 hours and 24 hours after the surgery</time_frame>
      <description>Postoperative pain levels will be assessed every 6 hours for the first 24 hours after the surgery using a numerical scale where 0 = no pain and 10 = worst pain imaginable</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Complications</measure>
      <time_frame>24 hours after the surgery</time_frame>
      <description>The rate of complications or adverse effects during the first 24 hours will be assessed, such as local anesthetic toxicity, nausea, vomiting, pruritus, acute urinary retention and motor block.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Quality of sleep</measure>
      <time_frame>24 hours after the surgery</time_frame>
      <description>The quality of sleep of the patient will be evaluated, rated on a scale where 0 = insomnia and 10 = excellent quality sleep.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Quality of postoperative recovery</measure>
      <time_frame>Change between baseline (day 0) and 72 hours and 7 days after the surgery</time_frame>
      <description>QoR15 is a valid questionnaire to measure the quality of recovery after surgery and anaesthesia, which includes 15 questions. Each of the 15 items are scored by the patient from 0 (worst score) to 10 (optimal score), giving a lowest possible score of 0 (worst outcome), and a highest possible score of 150 (optimal outcome).</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Patient's satisfaction</measure>
      <time_frame>24 hours and 7 days after the surgery</time_frame>
      <description>The satisfaction of the patient will be evaluated, rated on a scale where 0 = completely dissatisfied and 10 = fully satisfied.</description>
    </secondary_outcome>
    <number_of_arms>2</number_of_arms>
    <enrollment type="Anticipated">90</enrollment>
    <condition>Post-operative Pain</condition>
    <condition>Anesthesia, Local</condition>
    <arm_group>
      <arm_group_label>Para-Sartorial Compartment (PACS) Block + Femoral Triangle Block (FTB) + IPACK block</arm_group_label>
      <arm_group_type>Experimental</arm_group_type>
      <description>In addition to the injection performed in the femoral triangle, two injections of 5 mL of 0.5% ropivacaine will be performed below the sartorius muscle (subsartorial compartment) and above the sartorius muscle (suprasartorial compartment).&#xD;
  For all patients, an infiltration between popliteal artery and capsule of the knee block (IPACK) will be performed concomitantly, in order to block the sensory branches of the innervation posterior to the knee with 20 ml of ropivacaine 0.3%.</description>
    </arm_group>
    <arm_group>
      <arm_group_label>Femoral Triangle Block (FTB) + IPACK block</arm_group_label>
      <arm_group_type>Active Comparator</arm_group_type>
      <description>This block is currently the most used in practice and is considered a standard of care. It consists of a single injection of 15 ml of 0.5% ropivacaine under the sartorius muscle, lateral to the femoral artery, at the level of the apex of the femoral triangle&#xD;
  For all patients, an infiltration between popliteal artery and capsule of the knee block (IPACK) will be performed concomitantly, in order to block the sensory branches of the innervation posterior to the knee with 20 ml of ropivacaine 0.3%.</description>
    </arm_group>
    <intervention>
      <intervention_type>Procedure</intervention_type>
      <intervention_name>Para-Sartorial Compartments (PACS) Block + Femoral Triangle Block (FTB) + infiltration between popliteal artery and capsule of the knee block (IPACK)</intervention_name>
      <description>This intervention was selected because it has the potential to optimize analgesia by skin coverage of the upper third of the surgical incision. The intervention will be performed as follows:&#xD;
  The intermediate femoral cutaneous nerve will be visualized at the supralateral level of the sartorius muscle, in a duplicature of the fascia lata.&#xD;
  The needle will be inserted at the same puncture site as for the femoral triangle block, with a latero-medial orientation in the plane (intracanalar compartment).&#xD;
  In addition to the injection performed in the femoral triangle, two injections of 5 mL of 0.5% ropivacaine will be performed in addition, below the sartorius muscle (subsartorial compartment) and above the sartorius muscle (suprasartorial compartment).</description>
      <arm_group_label>Para-Sartorial Compartment (PACS) Block + Femoral Triangle Block (FTB) + IPACK block</arm_group_label>
    </intervention>
    <intervention>
      <intervention_type>Procedure</intervention_type>
      <intervention_name>Femoral Triangle Block (FTB) + infiltration between popliteal artery and capsule of the knee block (IPACK)</intervention_name>
      <description>The high frequency linear ultrasound probe will be positioned midway between the superior edge of the patella and the anterosuperior iliac spine. It will then be moved to visualize the apex of the femoral triangle, confirmed by visualization of the sartorius muscle laterally and the long adductor medially.&#xD;
  The needle will be inserted with a latero-medial orientation in the plane.&#xD;
  The initial injection will be a single injection of 15 ml of 0.5% ropivacaine under the sartorius muscle, lateral to the femoral artery, at the level of the apex of the femoral triangle.</description>
      <arm_group_label>Femoral Triangle Block (FTB) + IPACK block</arm_group_label>
    </intervention>
    <eligibility>
      <criteria>
        <textblock>
          Inclusion Criteria:&#xD;
  &#xD;
            -  18 years and over, requiring a primary total knee arthroplasty&#xD;
  &#xD;
            -  'American Society of Anesthesiologists' classification 1 to 3&#xD;
  &#xD;
          Exclusion Criteria:&#xD;
  &#xD;
            -  Refusal or unable to consent&#xD;
  &#xD;
            -  Contraindications to a peripheral nerve block;&#xD;
  &#xD;
            -  Inability to communicate with the healthcare team or the research team;&#xD;
  &#xD;
            -  Inability to understand follow-up instructions or questionnaires;&#xD;
  &#xD;
            -  Chronic pain requiring the intake of the equivalent of more than 60 mg of morphine&#xD;
               daily;&#xD;
  &#xD;
            -  Pregnancy;&#xD;
  &#xD;
            -  Patients weighing less than 55 kg (to limit the risk of intoxication with local&#xD;
               anesthetics).&#xD;
        </textblock>
      </criteria>
      <gender>All</gender>
      <minimum_age>18 Years</minimum_age>
      <maximum_age>N/A</maximum_age>
      <healthy_volunteers>No</healthy_volunteers>
    </eligibility>
    <overall_official>
      <last_name>Maxim Roy, MD, FRCPC</last_name>
      <role>Principal Investigator</role>
      <affiliation>Centre hospitalier de l'Université de Montréal (CHUM)</affiliation>
    </overall_official>
    <overall_contact>
      <last_name>Maxim Roy, MD, FRCPC</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>12132</phone_ext>
      <email>maxim.roy20@gmail.com</email>
    </overall_contact>
    <overall_contact_backup>
      <last_name>Julie Desroches, Ph. D</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>24542</phone_ext>
      <email>anesthesie.recherche.chum@ssss.gouv.qc.ca</email>
    </overall_contact_backup>
    <location>
      <facility>
        <name>Centre Hospitalier de l'Université de Montréal (CHUM)</name>
        <address>
          <city>Montreal</city>
          <state>Quebec</state>
          <zip>H2X 3E4</zip>
          <country>Canada</country>
        </address>
      </facility>
      <contact>
        <last_name>Julie Desroches, PhD</last_name>
        <phone>514-890-8000</phone>
        <phone_ext>24542</phone_ext>
        <email>anesthesie.recherche.chum@ssss.gouv.qc.ca</email>
      </contact>
      <contact_backup>
        <last_name>Vicky Thiffault, RN, CCRP</last_name>
        <phone>514-890-8000</phone>
        <phone_ext>24542</phone_ext>
        <email>anesthesie.recherche.chum@ssss.gouv.qc.ca</email>
      </contact_backup>
    </location>
    <location_countries>
      <country>Canada</country>
    </location_countries>
    <verification_date>September 2023</verification_date>
    <study_first_submitted>August 29, 2023</study_first_submitted>
    <study_first_submitted_qc>September 8, 2023</study_first_submitted_qc>
    <study_first_posted type="Actual">September 15, 2023</study_first_posted>
    <last_update_submitted>September 8, 2023</last_update_submitted>
    <last_update_submitted_qc>September 8, 2023</last_update_submitted_qc>
    <last_update_posted type="Actual">September 15, 2023</last_update_posted>
    <responsible_party>
      <responsible_party_type>Sponsor</responsible_party_type>
    </responsible_party>
    <keyword>total knee replacement surgery</keyword>
    <keyword>para-sartorial compartments block</keyword>
    <keyword>femoral triangle block</keyword>
    <condition_browse>
      <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
      <mesh_term>Pain, Postoperative</mesh_term>
    </condition_browse>
    <patient_data>
      <sharing_ipd>No</sharing_ipd>
    </patient_data>
    <!-- Results have not yet been posted for this study                                          -->
  </clinical_study>
  
  
text: download date: ClinicalTrials.gov processed this data on September 20, 2023
  link text: Link to the current ClinicalTrials.gov record.
  url: https://clinicaltrials.gov/ct2/show/NCT06038851
  org study id: 23.116
  nct id: NCT06038851
  lead sponsor: 
  has dmc: No
  is fda regulated drug: No
  is fda regulated device: No
  Total knee replacement surgery can be associated with a significant postoperative pain burden
        and an inability to mobilize adequately, which can lead to the failure of the ambulatory
        course.
  
        Indeed, early mobilization is beneficial in this context in order to prevent complications
        related to immobility.
  
        The optimization of postoperative analgesia is therefore a key issue for the success of this
        intervention in an outpatient setting or during a short-term hospitalization since an
        adequate pain relief facilitate the earlier mobilization of the operated joint. Modern
        postoperative analgesia protocols recommend a multimodal approach, including the use of
        acetaminophen, anti-inflammatories, opioids and others as well as the use of nerve blocks.
  
        Some nerve blocks used for total knee replacement surgery, such as the femoral nerve block,
        do not preserve the motor skills of the operated limb, which may alter the clinical
        trajectory due to delayed mobilization due to weakening of the quadriceps, one of the
        extensor muscles of the knee. Currently, one of the blocks used to spare the motor functions
        is the block of the femoral triangle.
  
        Unfortunately, this block of the femoral triangle does not fully cover the skin component of
        the surgical incision used for a total knee arthroplasty. A solution to obtain a better
        quality of pain relief at the level of the cutaneous incision would be to add a block of the
        para-sartorial compartment, which makes it possible to cover the nerve territories not
        covered by the femoral triangle block.
  
        The hypothesis of this study is that the addition of the para-sartorial compartments (PACS)
        block, which aims to block the intermediate cutaneous femoral nerve, will improve the
        postoperative analgesia after total knee replacement surgery, compared to the classical
        isolated approach of the femoral triangle block (FTB).
  Despite many advances, the postoperative analgesia offered by the present techniques remains
        imperfect, the femoral triangle block does not make it possible to completely cover the
        cutaneous component of the classic midline incision used for a total knee arthroplasty. This
        incision would fall more under the anterior cutaneous femoral nerves, more specifically the
        intermediate and medial cutaneous femoral nerves. A recently described approach offers the
        prospect of better covering this skin incision, by specifically blocking these nerves using
        the same needle path as for the femoral triangle block. Although the feasibility of this
        approach has been studied in healthy volunteers and in a few clinical cases, no randomized
        controlled study has been conducted to determine whether the addition of cutaneous femoral
        nerve blocks offers an analgesic benefit in the population undergoing total knee replacement
        surgery. This is therefore necessary in order to assess whether this approach improves the
        clinical trajectory of patients receiving a total knee arthroplasty.
  allocation: Randomized
  intervention model: Parallel Assignment
  intervention model description: Single-center, prospective superiority study, randomized controlled, triple blind
  primary purpose: Prevention
  masking: Triple (Participant, Care Provider, Outcomes Assessor)
  measure: Total morphine consumption
  time frame: 24 hours after the surgery
  measure: Time between the end of surgery and the first opioid dose
  time frame: 24 hours after the surgery
  measure: Intensity of the postoperative pain
  time frame: 24 hours, 72 hours and 7 days after the surgery
  description: The Pain Intensity short form is universal rather than disease-specific. The first two items in the Pain Intensity item bank assess pain intensity utilizing a 7-day recall period (items include the phrase "the past 7 days") while the last item asks patient to rate their pain intensity "right now."
  measure: Percentage of time spent with moderate to severe pain
  time frame: 6 hours, 12 hours, 18 hours and 24 hours after the surgery
  description: Percentage of time spent with moderate to severe pain (> 4/10) using a numerical scale where 0 = no pain and 10 = worst pain imaginable
  measure: Minimum pain after the surgery
  time frame: 24 hours after the surgery
  description: Minimum pain reported by the patient, rated on a numerical scale where 0 = no pain and 10 = worst pain imaginable.
  measure: Maximum pain after the surgery
  time frame: 24 hours after the surgery
  description: Maximum pain reported by the patient, rated on a numerical scale where 0 = no pain and 10 = worst pain imaginable.
  measure: Pain levels
  time frame: 6 hours, 12 hours, 18 hours and 24 hours after the surgery
  description: Postoperative pain levels will be assessed every 6 hours for the first 24 hours after the surgery using a numerical scale where 0 = no pain and 10 = worst pain imaginable
  measure: Complications
  time frame: 24 hours after the surgery
  description: The rate of complications or adverse effects during the first 24 hours will be assessed, such as local anesthetic toxicity, nausea, vomiting, pruritus, acute urinary retention and motor block.
  measure: Quality of sleep
  time frame: 24 hours after the surgery
  description: The quality of sleep of the patient will be evaluated, rated on a scale where 0 = insomnia and 10 = excellent quality sleep.
  measure: Quality of postoperative recovery
  time frame: Change between baseline (day 0) and 72 hours and 7 days after the surgery
  description: QoR15 is a valid questionnaire to measure the quality of recovery after surgery and anaesthesia, which includes 15 questions. Each of the 15 items are scored by the patient from 0 (worst score) to 10 (optimal score), giving a lowest possible score of 0 (worst outcome), and a highest possible score of 150 (optimal outcome).
  measure: Patient's satisfaction
  time frame: 24 hours and 7 days after the surgery
  description: The satisfaction of the patient will be evaluated, rated on a scale where 0 = completely dissatisfied and 10 = fully satisfied.
  arm group label: Para-Sartorial Compartment (PACS) Block + Femoral Triangle Block (FTB) + IPACK block
  arm group type: Experimental
  description: In addition to the injection performed in the femoral triangle, two injections of 5 mL of 0.5% ropivacaine will be performed below the sartorius muscle (subsartorial compartment) and above the sartorius muscle (suprasartorial compartment).
  For all patients, an infiltration between popliteal artery and capsule of the knee block (IPACK) will be performed concomitantly, in order to block the sensory branches of the innervation posterior to the knee with 20 ml of ropivacaine 0.3%.
  arm group label: Femoral Triangle Block (FTB) + IPACK block
  arm group type: Active Comparator
  description: This block is currently the most used in practice and is considered a standard of care. It consists of a single injection of 15 ml of 0.5% ropivacaine under the sartorius muscle, lateral to the femoral artery, at the level of the apex of the femoral triangle
  For all patients, an infiltration between popliteal artery and capsule of the knee block (IPACK) will be performed concomitantly, in order to block the sensory branches of the innervation posterior to the knee with 20 ml of ropivacaine 0.3%.
  intervention type: Procedure
  intervention name: Para-Sartorial Compartments (PACS) Block + Femoral Triangle Block (FTB) + infiltration between popliteal artery and capsule of the knee block (IPACK)
  description: This intervention was selected because it has the potential to optimize analgesia by skin coverage of the upper third of the surgical incision. The intervention will be performed as follows:
  The intermediate femoral cutaneous nerve will be visualized at the supralateral level of the sartorius muscle, in a duplicature of the fascia lata.
  The needle will be inserted at the same puncture site as for the femoral triangle block, with a latero-medial orientation in the plane (intracanalar compartment).
  In addition to the injection performed in the femoral triangle, two injections of 5 mL of 0.5% ropivacaine will be performed in addition, below the sartorius muscle (subsartorial compartment) and above the sartorius muscle (suprasartorial compartment).
  arm group label: Para-Sartorial Compartment (PACS) Block + Femoral Triangle Block (FTB) + IPACK block
  intervention type: Procedure
  intervention name: Femoral Triangle Block (FTB) + infiltration between popliteal artery and capsule of the knee block (IPACK)
  description: The high frequency linear ultrasound probe will be positioned midway between the superior edge of the patella and the anterosuperior iliac spine. It will then be moved to visualize the apex of the femoral triangle, confirmed by visualization of the sartorius muscle laterally and the long adductor medially.
  The needle will be inserted with a latero-medial orientation in the plane.
  The initial injection will be a single injection of 15 ml of 0.5% ropivacaine under the sartorius muscle, lateral to the femoral artery, at the level of the apex of the femoral triangle.
  arm group label: Femoral Triangle Block (FTB) + IPACK block
  criteria: 
  gender: All
  minimum age: 18 Years
  maximum age: N/A
  healthy volunteers: No
  last name: Maxim Roy, MD, FRCPC
  role: Principal Investigator
  affiliation: Centre hospitalier de l'Université de Montréal (CHUM)
  last name: Maxim Roy, MD, FRCPC
  phone: 514-890-8000
  phone ext: 12132
  email: maxim.roy20@gmail.com
  last name: Julie Desroches, Ph. D
  phone: 514-890-8000
  phone ext: 24542
  email: anesthesie.recherche.chum@ssss.gouv.qc.ca
  facility: 
  contact: 
  contact backup: 
  country: Canada
  responsible party type: Sponsor
  mesh term: Pain, Postoperative
  sharing ipd: No